BioSpace News Archive

Business

Tilray® Announces Global Senior Leadership Appointments

Former Coca-Cola, Starbucks, Nestle and Diageo executives join pioneering cannabis company

January 31, 2019
·
5 min read
Deals

Biotage AB - Changes in Number of Shares and Votes

As previously announced, Biotage AB has during January 2019 issued 487,337 new shares in connection with the acquisition of PhyNexus, Inc.

January 31, 2019
·
1 min read
Policy

SIRAKOSS Receives CE Mark for Osteo3 Synthetic Bone Graft Substitute

Represents New Hope for Repairing Challenging Bone Fractures

January 31, 2019
·
3 min read
Business

Gradiant Secures Four Water Recycling Projects in India, Highlights Importance of Superior and Affordable Wastewater Treatment

Expands operations in India with four Zero Liquid Discharge (ZLD) projects in the textile processing, dyestuff and alkali-chemical manufacturing, and pharmaceutical industries

January 31, 2019
·
4 min read
Business

Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET

Applied DNA Sciences, Inc., announced it plans to release financial results for its fiscal 2019 first quarter ended December 31, 2018 after market close on Thursday, February 7, 2019.

January 31, 2019
·
2 min read
Business

West to Host Fourth-Quarter and Full-Year 2018 Conference Call

West Pharmaceutical Services, Inc. announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday, February 14, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

January 31, 2019
·
2 min read
FDA

FDA Expands Lilly’s ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer

New approval based on Phase 3 KEYNOTE-189 results

January 31, 2019
·
16 min read
Business

AmerisourceBergen Reports Fiscal 2019 First Quarter Results

Revenues of $45.4 Billion for the First Quarter, a 12.2 Percent Increase Year-Over-Year

January 31, 2019
·
36 min read
Drug Development

REGENXBIO Receives Rare Pediatric Disease Designation for RGX-181 Gene Therapy for the Treatment of CLN2 Form of Batten Disease

Novel, one-time investigational treatment for CLN2 disease designed to halt progression of this rare, pediatric, neurodegenerative disease

January 31, 2019
·
7 min read
Biotech Bay

AcelRx Pharmaceutical’s sufentanil sublingual tablet (DSUVIA) to be highlighted during a presentation at the Boswick Burn and Wound Symposium

The symposium will take place February 2-7, 2019.

January 31, 2019
·
10 min read